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Abstract Heat-shock protein 60 (Hsp60) is ubiquitous and
highly conserved being present in eukaryotes and prokary-
otes, including pathogens. This chaperonin, although typi-
cally a mitochondrial protein, can also be found in other
intracellular sites, extracellularly, and in circulation. Thus, it
can signal the immune system and participate in the devel-
opment of inflammation and immune reactions. Both phe-
nomena can be elicited by human and foreign Hsp60 (e.g.,
bacterial GroEL), when released into the blood by infectious
agents. Consequently, all these Hsp60 proteins become part
of a complex autoimmune response characterized by multi-
ple cross reactions because of their structural similarities. In
this study, we demonstrate that Hsp60 proteins from humans
and two common pathogens, Chlamydia trachomatis and
Chlamydia pneumoniae, share various sequence segments of
potentially highly immunogenic epitopes with acetylcholine
receptor a1 subunit (AChRa1). The structural data indicate
that AChRa1 antibodies, implicated in the pathogenesis of
myasthenia gravis, could very well be elicited and/or main-
tained by self- and/or bacterial Hsp60.
Keywords Shared epitopes  Molecular mimicry 
Autoimmunity  Neuromuscular disorder
Introduction
Unfolded or misfolded proteins may interfere with the
machinery of the cell. For this reason, prokaryotic and
eukaryotic cells have evolved special macromolecular
‘‘chaperone’’ complexes that capture and refold partially
folded proteins (Ellis 2007). First observed in cells exposed
to high temperatures, heat shock proteins (Hsps) have been
identified as chaperones and found to increase in response
to a number of cell stress stimuli (Haak and Kregel 2008).
Chaperonins, a subset of chaperones, are classified in two
groups: those belonging to Group I are found in bacteria
(GroEL) and eukaryotic organelles (mitochondrial Hsp60,
often called also Cpn60), while Group II chaperonins are
present in archaea (thermosome subunits) and eukaryotic
cytoplasm (CCT) (Macario et al. 1999).
The mitochondrial Hsp60 (hereinafter ‘‘Hsp60’’) is one
of the most conserved human molecular chaperones and is
also present in several kinds of pathogens (Sakamoto and
Ohkuma 2010). In eukaryotic cells, this protein is classi-
cally considered an intracellular chaperone, working toge-
ther with its co-chaperonin Hsp10 to assist in the folding of
other mitochondrial proteins (Horwich et al. 2007; Lund
2009). Hsp60 has also been found in extra-mitochondrial
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sites, as well as in the extracellular environment and
bloodstream, and thus can stimulate the innate and the
adaptive immune systems (Habich and Burkart 2007;
Henderson 2010; Quintana and Cohen 2011). Hsp60 acti-
vates macrophages and dendritic cells, stimulates produc-
tion of pro-inflammatory molecules, and leads to activation
of Hsp60-specific T cell responses. Moreover, both micro-
bial and human Hsp60 are strongly antigenic and can trigger
the production of relatively large amounts of antibodies.
Not surprisingly, autoantibodies to self-Hsp60 are detected
in several autoimmune and inflammatory diseases (Quin-
tana and Cohen 2011).
Myasthenia gravis (MG) is a neuromuscular disorder
caused by a T-cell-dependent and B-cell-mediated autoim-
mune response to the muscle-type nicotinic acetylcholine
receptor (AChR), which compromises neuromuscular
transmission (Moiola et al. 1998; Hohlfeld and Wekerle
2008; Le Panse et al. 2008; Helgeland et al. 2011). The
crystal structure of AChR reveals an allosteric membrane
glycoprotein constituted of five subunits (two a1 subunits,
one b, one d, one c for embryonic stage, and one e subunit for
adult stage). For each subunit, extracellular, transmembrane,
and cytoplasmic domains can be distinguished. The extra-
cellular a1 subunits’ domain contains, at the apex, the main
immunogenic region (MIR), comprising residues 67–76
called ‘‘the MIR loop’’ and, half way up at the ad subunit
interface, the high-affinity acetylcholine (ACh)-binding site
called loop C, shaped by residues Y190, C192, C193, and Y198
(Arias 2000). The MIR is a conformation-dependent region
with immunogenic relevance for its prominent location,
acting as a antigenic epitope in MG (Brejc et al. 2001). The
presence of this region might allow native AChRs to be
effective in binding to receptor immunoglobulins on the
surface of pre-B lymphocytes (Lindstrom et al. 2008). Sev-
eral experiments, carried out by creating chimeras of human
a1 subunits, have demonstrated that half or more of the
autoantibodies to AChR in MG are directed against MIR,
thus confirming its prominent pathogenetic role (Lindstrom
et al. 2008; Luo et al. 2009). Moreover, the presence of the a1
MIR sequence in chimeric AChR greatly influences its
sensitivity to activation by Ach (Luo et al. 2009). In a1
subunits, conformation maturation of the MIR and the
ACh-binding site occurs simultaneously before assembly,
revealing the structural and functional significance of the
former (Brejc et al. 2001; Luo et al. 2009).
The question is: How do anti-AChR antibodies arise? We
previously reported several highly homologous amino-acid
sequences when comparing human and Chlamydial Hsp60
with various subunits of human AChRs (Cappello et al. 2010).
In the present study, we extended our search to all the
homologous epitopes that result from the comparison between
the amino-acid sequences of AChRa1 and Homo sapiens
Hsp60 (Hs-Hsp60), or Chlamydia trachomatis GroEL
(Ct-Hsp60), or Chlamydia pneumoniae GroEL (Cp-Hsp60).
We also mapped these epitopes within the three-dimensional
structure of the AChRa1 molecule with particular attention to
the MIR and the ACh-binding site. Our results support the
hypothesis of cross-reactivity between human and Chlamydial
Hsp60s with AChR, which would lead to a humoral anti-
Hsp60 immune response that would also react with AChR
and, thus, contribute to the pathogenesis of MG.
Methods
The amino-acid sequences of AChRa1, Hs-Hsp60,
Ct-Hsp60, and Cp-Hsp60 were obtained from the PubMed
website (http://www.ncbi.nlm.nih.gov/genbank/) using the
access numbers Y00762, NM002156, AJ783840, and
AAP98858, respectively. Sequence comparisons were per-
formed using the SIM software (http://expasy.org/tools/
sim-prot.html), and a three-dimensional model of AChRa1
monomer was obtained using the 3D-JIGSAW software
Table 1 Sequence segments of high similarity in human and chla-
mydial Hsp60 proteins shared with AChRa1
Hsp60 amino-acid sequences
compared to AChRa1 from
Amino
acid
position
Percent
similarity
Extracellular
AChRa1
epitope
Homo sapiens
LIVEKIMQSSSEV 489–501 53.8 No
FEKISKGANPVEIRRG 128–143 38.9 Yes
VIAELKKQSKPVTTPEE 155–171 35.3 Yes
AIATGGAGEE 317–326 33.3 Yes
Chlamydia trachomatis
AGLLLTTE 512–519 62.5 Yes
GGVAVIRV 373–380 50.0 Yes
NIKYNEEARKKIQK 5–18 28.6 Yes
IKYNEEARKKIQKGVKTL 6–23 27.6 Yes
Chlamydia pneumoniae
SEQEKLSNY 2–10 55.6 Yes
SEQNQHLIIFCEDID 235–249 53.3 No
DGDAVIAKLSSL 448–459 41.7 Yes
IVKGSYGPKQSLS 26–38 38.5 Yes
YNADKKLFS
GIDKLFQIVK
10–28 36.8 Yes
LGVDFAKAMVNK
IHKEHS
63–80 33.3 Yes
YENLGVDFAKAMV
NKIHKEHSDGAT
60–84 28.0 Yes
PKQSLSPTSFFKE
RGFYAISQT
33–54 27.3 Yes
LQEALQQQSWPIKDA 121–135 26.7 Yes
LHAILQESYAALEKGIS
THKLIASLKLQGEKLQ
90–122 18.2 Yes
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(http://bmm.cancerresearchuk.org/*3djigsaw/) and visual-
ized by PyMol (http://www.pymol.org/). All software used
are open access.
Results and Discussion
The alignment of the amino-acid sequences of Hs-Hsp60
and AChRa1 revealed four epitopes with a percentage of
similarity (identities plus conservative substitutions) com-
prised between 33.3 and 53.8 (Table 1). Likewise, the
alignment of the amino-acid sequences of Ct-Hsp60 and
AChRa1 showed four homologous epitopes with a simi-
larity percentage comprised between 27.6 and 62.5. The
comparison of the amino-acid sequences of Cp-Hsp60 and
AChRa1 revealed 10 homologous epitopes with a per-
centage of similarity comprised between 18.2 and 55.6.
Interestingly, these epitopes were mostly localized around
Fig. 1 Three-dimensional model of AChRa1 monomer showing shared
amino-acid sequences (potential immunogenic-antigenic epitopes) with
the Hs-Hsp60 and its chlamydial counterparts. a Shown are the Mir (blue
loop, bottom left corner insert) and the ACh-binding site (ACh-bs; hot
pink discontinuous loop, top right corner insert). b Homologous epitopes
revealed by the alignment of AChRa1 and Hs-Hsp60 sequences. One
epitope maps to the transmembrane region of AChRa1 (red helix, aa
489-501), while another three epitopes (shown by white thick arrows)
map to around the Mir. c Homologous epitopes revealed by the alignment
of AChRa1 and Ct-Hsp60 sequences. Four epitopes (cyan helix and red
loops—see bottom left corner insert) map around and on to the Mir.
d Homologous epitopes revealed by the alignment of AChRa1 and Cp-
Hsp60 sequences. Of the 10 shared sequences, only one (shown by a
white arrow, aa 235–249) maps to the intracellular region of AChRa1,
whereas all the rest (various colors; see insert down to the left) map
around and on the ACh-binding site (color figure online)
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or inside either the MIR or the ACh-binding site of
AChRa1 (Fig. 1).
Hsp60 of pathogenic eukaryotes and prokaryotes share
numerous highly homologous (if not identical) amino-acid
sequences distributed along the entire Hsp60 sequence with
the potential of eliciting, by molecular mimicry, the pro-
duction of cross-reactive antibodies after infection with
these pathogens (Cappello et al. 2009). For example,
GroEL of Chlamydiaceae share several epitopes with
Hs-Hsp60 (Campanella et al. 2009). Thus, chlamydial
Hsp60 represents a common dominant bacterial antigen,
and immune responses to this pathogen are characterized
by the production of antibodies to it (Cappello et al. 2009).
As a consequence, the potential cross-reactivity between
the microbial chaperonin and its human counterpart may
predispose to autoimmunity. Recurrent infections and the
ensuing prolonged antibody response may cause the
exacerbation of an underlying autoimmune disease. In
addition, enhanced expression of Hs-Hsp60 under stress
conditions can also unveil previously silent antigenic
determinants that can initiate and perpetuate autoimmune
reactivity (Quintana and Cohen 2011).
There is extensive information about the association
between autoantibodies to Hs-Hsp60 and the development
of various autoimmune and inflammatory diseases,
including type 1 diabetes, rheumatoid arthritis, multiple
sclerosis, lupus, atherosclerosis, Behc¸et’s disease, and
inflammatory bowel disease (Quintana and Cohen 2011).
However, very little is known about the humoral immune
response to Hsp60 in MG, while the clinical association
between chlamydial infection and MG has not been
examined before. By contrast, the involvement of molec-
ular mimicry for antigens from other bacterial infections
(like M. pnuemoniae and S. thyphimurium) has been
already postulated (Deitiker et al. 2000).
In this study, we found several potentially immunogenic
epitopes that are located in the extracellular region of
AChRa1, around and inside the MIR or the ACh-binding
site, that are also present in Hsp60. These results strongly
support the notion that human and bacterial Hsp60 might
play a key role in the development of an autoimmune
response against AChRa1. Thus, AChRa1 would become
target for antibodies elicited by self- or foreign Hsp60,
for example, during a chlamydial infection. If so, myas-
thenia gravis should also be considered a chaperonopathy
(Macario et al. 2010), in which normal chaperones play a
role in pathogenesis rather than the reverse, and therapeutic
efforts should include blocking the chaperonins or their
antibodies, or both.
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